GenScript Launched first fastest covid test kit in the world

Vastavam web: GenScript Biotech Corporation, a leading global biotechnology company today announced a strategic sales distribution agreement, appointing Premas Life Sciences as the exclusive technology and knowledge distributor of cPassTM SARS CoV-2 Neutralization Antibody Detection Kit in India. It is the first-in-the-world “rapid test kit” which can measure neutralizing antibodies within an hour and it will be a huge boost to current COVID-19 investigations, sero-prevalence survey, and research on herd immunity, longevity of protecting neutralizing antibodies and efficacy of different vaccine candidates.

his test would be instrumental in vaccine and therapeutic development as it is suitable for all antibody isotypes and can be used to determine antibodies in different animal models without any modification. GenScript Biotech Corporation along with Premas Life Sciences will provide in-depth technical support to allow customers in India to have the access to cPassTM SARS CoV-2 Neutralization Antibody Detection Kit and ramp up the current efforts in COVID-19 testing and vaccine development.